StonvexLoading…
StonvexStonvexStonvexCore line items from GLBE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $962.20M | $752.76M | $569.95M | $409.05M |
Operating Income | $71.67M | $-67.93M | $-137.06M | $-189.32M |
Net Income | $68.27M | $-75.55M | $-133.81M | $-195.41M |
EPS (Diluted) | $0.39 | $-0.45 | $-0.81 | $-1.24 |
Total Assets | $1.46B | $1.26B | $1.20B | $1.16B |
Total Liabilities | $530.10M | $370.05M | $300.38M | $234.48M |
Cash & Equivalents | $245.86M | $254.62M | $200.08M | $165.03M |
Free Cash Flow OCF − CapEx | $280.68M | $167.06M | $106.48M | $80.98M |
Shares Outstanding | 169.05M | 169.13M | 165.77M | 161.32M |